Login / Signup

Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study.

Ken InadaSakiko YamadaHisashi AkiyoshiYoshitsugu KojimaShuichi IwashitaJun Ishigooka
Published in: Neuropsychiatric disease and treatment (2020)
Brexpiprazole was shown to be safe and effective in the treatment of elderly Japanese patients with schizophrenia.
Keyphrases
  • major depressive disorder
  • middle aged
  • community dwelling
  • bipolar disorder
  • randomized controlled trial
  • combination therapy